Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Cantharidin Application in Molluscum Patients

ClinicalTrials.gov ID: NCT03377803

Public ClinicalTrials.gov record NCT03377803. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum

Study identification

NCT ID
NCT03377803
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Verrica Pharmaceuticals Inc.
Industry
Enrollment
262 participants

Conditions and interventions

Interventions

  • VP-102 - Cantharidin, Topical Film Forming Solution Combination Product
  • Placebo -Topical Film Forming Solution without VP-102 Combination Product

Combination Product

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 13, 2018
Primary completion
Sep 25, 2018
Completion
Sep 25, 2018
Last update posted
Dec 13, 2021

2018

United States locations

U.S. sites
15
U.S. states
9
U.S. cities
14
Facility City State ZIP Site status
Bakersfield Dermatology Bakersfield California 93309
Rady Children's Hospital San Diego California 92123
Redwood Family Dermatology Santa Rosa California 95403
Solution Through Advanced Research Jacksonville Florida 32256
Lenus Research and Medical Group Sweetwater Florida 33172
Northwestern Memorial Hospital Chicago Illinois 60611
Dermatology Center of Northwestern Indiana Crown Point Indiana 46307
Pedia Research Evansville Indiana 47715
Pedia Research Owensboro Kentucky 42301
Hamzavi Dermatology Fort Gratiot Michigan 48059
Midwest Children's Health-Northwoods Lincoln Nebraska 68505
Midwest Children's Health Lincoln Nebraska 68505
Tekton Research Austin Texas 78745
DCOL Center for Clinical Research Longview Texas 75605
The Education and Research Foundation Lynchburg Virginia 24501

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03377803, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 13, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03377803 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →